Bret Jensen
Bret Jensen is the lead equities analyst with Investors Alley. He's the editor of their newsletters including The Growth Stock Advisor and Biotech Gems.
Bret Jensen's Latest Posts
3 Undervalued Stocks On The Verge Of A Breakout
Buying shares at these prices might look like a gift in six month’s time. With multiple catalysts to fuel share price growth on the horizon and a lot of good news not yet baked into the share price, now is a great time to get in. The fairy tale story for biotech investors is buying […]
3 Stocks To Buy For A Decade Of Gains
Get the insider tip on three stocks with red-hot growth that could top your portfolio gains for the next 10 years. Bret Jensen sees seven specific reasons why these stocks deserve a spot in your portfolio. The Trump administration is still trying to pivot from failing to repeal and replace the Affordable Health Care Act. […]
3 Small Biotech Moonshots To Add To Your Portfolio
As the biotech sector heats up more in 2017, small stocks like the three in this article have already turned in some stellar performances. With the entire sector gaining steam, there’s still plenty of upside left. Bret Jensen recommends adding these three stocks to the portfolio. Sentiment on the biotech sector early in 2017 sure has […]
3 Turnaround Stocks For Quick Gains In 2017
After watching the biggest turnaround story in sports, Bret Jensen was inspired to pick out three stocks that have been “left for dead” by the market but have great chances to be resurrected in 2017. Each of these stocks has a tough road ahead but if successful could return investors huge wads of money. “When […]
5 Cheap Stocks With Strong Insider Buying
Finding value with drivers for growth while the market sits near all-time highs has become a challenge, but Bret Jensen has identified five stocks he thinks trade for too cheap and could rally higher on the back of strong insider buying. The market has greeted the unexpected election outcome with one of the biggest post-election […]
3 Biotech Stocks Set To Soar Under Republican Leadership
After being the market’s whipping boy for the last year, the biotech sector looks ready to rebound under a pro-business White House. Already, many stocks have shot up over 50%, but Bret Jensen shares three today that still have plenty of upside backed up by strong products already on the market. The biotech sector has […]
5 Stocks You’ve Never Heard Of Growing Double-Digits
Put some rapid growth into your portfolio with any of the five little-known stocks Bret Jensen recommends buying today. In today’s market, many popular stocks experiencing double-digit growth have been bid up to sky-high valuations but all five of these stocks are considered “Growth at a Reasonable Price.” It looks like profit growth within the […]
6 Undervalued Stocks With Strong Upcoming Catalysts
If all goes well for these six stocks, over the next year they could be worth significantly more than what currently trade for. Each stock has important, business-defining events that, if positive, would make their businesses much more valuable. “Uncertainty is the only certainty there is, and knowing how to live with insecurity is the […]
5 Deeply Undervalued Stocks With Great Dividends
Buy these five stocks today while their yields are high and their shares are cheap. With the rest of the market slightly overbought, purchasing these cheap dividend stocks with above-average yields will put you miles ahead of most investors who chase the hot stock of the minute. Income investors might not have been as comfortable […]
4 Cheap Stocks With Breakout Potential
Offering compelling value and rich upside, two increasingly rare qualities now that the market flirts with all-time highs, these four stocks should either be on your watchlist or in your portfolio. Overpaying for stocks is one of the surest ways to limit your returns. Alcoa (NYSE: AA) opened up third quarter earnings season this week. […]
